FindTrial
Sign In

To study the effectiveness between kokilakshadi kwath ghanvati and febuxostat in the management of vatarakta with special reference to gout in the age group of 35-65 years for lowering the level of sr.uric acid and symptoms of vatarakta

A randomized comparative clinical trial to evaluate the efficacy of kokilakshadi kwath ghanvati and febuxostat in the management of vatarakta with special reference to gout. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099342
Enrollment
70
Registered
2025-12-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M109- Gout, unspecified

Interventions

None listed

Sponsors

PDEAs College of Ayurveda and Research centre Nigdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patient whose sr. Uric acid is above 6.8 gm/dl and below 9 gm/dl 2.patients have fulfilling criteria such as sandhi shool ,sandhi stabdhata ,sandhi shoth ,sandhi daha . 3.affected joint especially 1st metatarsophalengial joint other affected joints of body also will be included

Exclusion criteria

Exclusion criteria: 1.Known case of amavata 2.known case of sandhigatavata 3.with known case of tuberculosis,HIV,trauma,cardiac disease 4.known case of peripheral vascular disease 5.pregnent and lactating women 6.habitual alcoholic patient 7.patient suffering from secondary gout

Design outcomes

Primary

MeasureTime frame
To compare the effectiveness of kokilakshadi kwath ghanvati 500 mg vyanodan Kal with normal water for 21 days and febuxostat 40 mg once a day after meal with normal water for 21 days in the management of vatarakta with special reference to gout.Timepoint: 21 days with follow up on 8th 15th 22nd day—

Secondary

MeasureTime frame
To observe and compare the adverse effect in two groups within 21 daysTimepoint: 21 days with follow up on 8th 15th 22nd day—

Countries

India

Contacts

Public ContactDr Rutuja jijaba Gawade

PDEAs College of Ayurveda and Research centre Nigdi Pune

khobragaderupali19@gmail.com8378929859

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026